US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

266.00

-13.0200-4.67%

Post-market: 264.12-1.8800-0.71%19:53 EDT

Volume:290.13K

Turnover:77.49M

Market Cap:498.61M

PE:- -

High:274.71

Open:269.37

Low:260.01

Close:279.02

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.94

T/O Rate:15.48%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live

Warning Signs; Buying Energy and Health Care; Still Cautious on QQQ and Now Also IWM

ResMed completes divestment of MatrixCare to Frazier Healthcare Partners

Analyst Reiterates Buy on Compass Therapeutics Ahead of Key FDA Catalyst; $7 Price Target Maintained

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)

Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

SEC, FDA Sign Agreement to Boost Information Sharing, Market Oversight

MT Newswires Live

Xianju Pharmaceutical Receives US FDA Filing Acceptance for Progesterone Vaginal Tablets

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Press Release: RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota(R) and Clenpiq(R)

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)

Alliance Healthcare Wins ALPS Tender for Mobile Inpatient Home Care Services

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/LABU/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":266,"timestamp":1789070400000,"preClose":279.02,"halted":0,"volume":290130,"hourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"delay":0,"changeRate":-0.046663321625689855,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Not Yet Opened","change":-13.02,"latestTime":"09-10 16:00:00 EDT","open":269.37,"high":274.705,"low":260.01,"amount":77488111.8858,"amplitude":0.052666,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":279.02,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003776,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":268.99,"preClose":279.02,"latestTime":"09:29 EDT","volume":1828,"amount":503835.0052,"timestamp":1789046962415,"change":-10.03,"changeRate":-0.035947,"amplitude":0.054249},"postHourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"volumeRatio":0.944317,"impliedVol":0.9105,"impliedVolPercentile":0.502},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.944317,"shares":1874486,"dividePrice":1.0045,"high":274.705,"amplitude":0.052666,"preClose":279.02,"low":260.01,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":266,"eps":0,"divideRate":0.003776,"volume":290130,"delay":0,"ttmEps":0,"open":269.37,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":311.81,"twentyDayClose":286.75,"sixtyDayClose":188.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664285481","title":"Sector Update: Healthcare Stocks Mixed Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2664285481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664285481?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:17","pubTimestamp":1788268638,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1% higher and the iShares Biotechnology ETF (IBB) down 0.5%Novartis (NVS) shares were up ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","IE00B42XCP33.USD","LU2468319806.SGD","MEDX","LU0106261372.USD","HCSG","LU1506573853.SGD","IE00B3PB1722.GBP","IE00BGHQF631.EUR","IE0009355771.USD","LU1244550494.USD","BK4532","LU0211326755.USD","LU1116320901.HKD","BK4588","LABU","LU1244550221.USD","LU0496365809.HKD","LU0432979614.USD","IE000M9KFDE8.USD","IE00B4R5TH58.HKD","IE00BFXG1179.USD","LU0070302665.USD","IE00BDGV0183.EUR","LU2271345857.HKD","NVS","LU1244550577.SGD","LU1983299246.USD","LU2023251221.USD","IE00BJT1NW94.SGD","MDT","LU1989771016.USD","LU1989764664.SGD","LU0211326839.USD","LU2112291526.USD","LU0320765489.SGD","IBB","LU1061106388.HKD","LU2089284900.SGD","XBI","XLV","LU0314106906.USD","LU1023059063.AUD","LU0211331839.USD","IE0002141913.USD","LU2111349929.HKD","LU0158827781.USD","MMED","PPH","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861272","title":"Warning Signs; Buying Energy and Health Care; Still Cautious on QQQ and Now Also IWM","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861272","media":"Smartkarma","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861272?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:48","pubTimestamp":1788266894,"startTime":"0","endTime":"0","summary":"utm_source=tiger_community","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smartkarma.com/home/private-investor-solutions/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","NOCT","URTY","BK4535","BK4534","AVUV","PSQ","SOXL","XLU","RSSL","IWF","BK4588","BK4561","MNQmain","RSP","TWM","SOXX","QDEC","BK4570","VTWO","SRTY","GPIQ","QID","QLD","RYLD","IWN","XBI","BK4593","NJAN","RWM","XLV","UWM","QQQM","SQQQ","BK4550","TQQY","SOXS","TNA","TECL","LABU","TZA","NDX","NAPR","QMAR","BK4581","QQQ","VB","IWMI","XLE","IWM","USSX","NJUL","BK4585","QQQX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851950","title":"ResMed completes divestment of MatrixCare to Frazier Healthcare Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851950","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851950?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:45","pubTimestamp":1788266735,"startTime":"0","endTime":"0","summary":"Resmed (RMD) announced the closing of its sale of MatrixCare to Frazier Healthcare Partners, a private equity firm focused on the healthcare indust...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/resmed-completes-divestment-of-matrixcare-to-frazier-healthcare-partners-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/resmed-completes-divestment-of-matrixcare-to-frazier-healthcare-partners-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0170899867.USD","LRCY","BK4504","XBI","BK4567","LGHT","CGCV","BK4588","NOBL","LU0128526141.USD","BK4581","RMD","BK4550","LU0029874061.USD","AAUM","PEVC","LU2177674079.SGD","TCAF","LABU","VHT","REDS","BK4137","BK4548","IXJ","RSBA","LU2008162690.USD","IE00B5TLWC47.USD","BK4082","HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859715","title":"Analyst Reiterates Buy on Compass Therapeutics Ahead of Key FDA Catalyst; $7 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859715","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859715?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:35","pubTimestamp":1788266156,"startTime":"0","endTime":"0","summary":"In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Compass Therapeutics, with a price target of $7.00. John ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-compass-therapeutics-ahead-of-key-fda-catalyst-7-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-compass-therapeutics-ahead-of-key-fda-catalyst-7-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","CMPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664512728","title":"Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2664512728","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664512728?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:31","pubTimestamp":1788265860,"startTime":"0","endTime":"0","summary":"Multi-site clinical study delivers strong performance data for Intelligent Fingerprinting Drug Screening SystemNEW YORK, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INB","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354170/0/en/intelligent-bio-solutions-achieves-above-98-accuracy-in-method-comparison-study-supporting-planned-2026-fda-510-k-submission.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851217","title":"Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851217","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851217?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:30","pubTimestamp":1788265800,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Ch","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354160/0/en/liquidia-corporation-to-participate-in-wells-fargo-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","LU2461242641.AUD","BK4207","LU1814569148.SGD","HCSG","LU1506573853.SGD","LU0868494617.USD","BK4559","FTXO","LU0942090050.USD","LU0708994859.HKD","LU0742534661.SGD","IE0002270589.USD","LU0310800965.SGD","IE000M9KFDE8.USD","LABU","LU0130517989.USD","LU0175139822.USD","LU1267930573.SGD","LU0048573561.USD","LU0052756011.USD","TFNS","LU0314106906.USD","WFC","LU0477156953.USD","IE00B19Z3581.USD","LU1267930227.SGD","LU0289960550.SGD","LU0070302665.USD","LU0256863811.USD","LU0211327993.USD","LU1074936037.SGD","LU0310799852.SGD","PGF","BK4501","IYF","LU0128525689.USD","KBWB","LU0211328371.USD","LU0320765489.SGD","LU0128525929.USD","LU1894683348.USD","XBI","LU1280957306.USD","LU0980610538.SGD","LU1267930490.SGD","LQDA","LU0072461881.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859516","title":"Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859516?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:10","pubTimestamp":1788264606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viridian Therapeutics (VRDN), Teladoc (TDOC) and P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-teladoc-tdoc-and-protagonist-therapeutics-ptgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-teladoc-tdoc-and-protagonist-therapeutics-ptgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4504","BK4139","XLV","PTGX","BK4585","LABU","LU0029874061.USD","BK4167","BK4548","BK4567","LU1861559042.SGD","BK4534","LU1861558580.USD","LU0128526141.USD","BK4137","XBI","BK4588","HCSG","TDOC","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885625","title":"Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885625","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885625?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  01, 2026  -- Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference, which will take place in Boston, September 8 – 10, 2026. During meetings, management will discuss its commercial products and its robust pipeline of clinical stage kidney disease programs. About Akebia TherapeuticsAkebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release. Akebia Therapeutics ContactMercedes Carrascomcarrasco@akebia.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354088/37519/en/akebia-therapeutics-to-conduct-investor-meetings-at-the-2026-wells-fargo-healthcare-conference-in-boston.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0029864427.USD","LU0980610538.SGD","LU1035773651.USD","LU0256863811.USD","LU0683600562.USD","LU1363072403.SGD","LU0742534661.SGD","IYF","HCSG","LU0267386448.USD","LU2361045086.USD","LU0128525689.USD","LU0971096721.USD","LU0310800379.SGD","AKBA","KBWB","LU0787776722.HKD","XLV","LU0868494708.USD","LU1668664300.SGD","BK4501","XBI","LU0208291251.USD","PGF","LU0149725797.USD","BK4588","LU1894683348.USD","LU0175139822.USD","FTXO","LU0130102774.USD","LU0251142724.SGD","LU0052756011.USD","LU0310800965.SGD","LU2361044865.SGD","LU1267930490.SGD","LU0048573561.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0640476718.USD","IE00B19Z3B42.SGD","LU0310799852.SGD","LU1506573853.SGD","LABU","TFNS","LU0162691827.USD","LU1069347547.HKD","BK4139","LU0154236417.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEMS","FBT","BK4588","TBXU","BK4137","LU0128526141.USD","MEDI","CNCR","SYNB","XBI","XLV","BK4505","LEGN","GNOM","BK4139","IBB","LFSC","IBBQ","LABU","LU0029874061.USD","BK4585","BK4581","HCSG","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664562148","title":"Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664562148","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664562148?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354046/0/en/metagenomi-therapeutics-inc-to-present-at-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","LU0868494617.USD","LU2236285917.USD","LU1074936037.SGD","HCSG","LU1506573853.SGD","LU0128525929.USD","LU0128526141.USD","LU0149725797.USD","LU2361044865.SGD","LU0130517989.USD","IE00B19Z3B42.SGD","LU0128525689.USD","MGX","LU0154236417.USD","LU2361044949.HKD","IYF","LU0256863811.USD","LENZ","KBWB","LABU","LU0310800965.SGD","IE000M9KFDE8.USD","TFNS","LU0211327993.USD","LU0106831901.USD","FTXO","LU0175139822.USD","PGF","LU0048573561.USD","LU0971096721.USD","XBI","LU0417517546.SGD","XLV","LU0208291251.USD","BK4007","LU0314106906.USD","LU0477156953.USD","LU1363072403.SGD","BK4559","LU1668664300.SGD","BK4501","LU1267930490.SGD","BK4539","LU0211328371.USD","LU0029864427.USD","LU0130102774.USD","LU0072461881.USD","LU0787776722.HKD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485625","title":"Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485625","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485625?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"CORAL GABLES, Fla., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354047/0/en/relmada-therapeutics-to-participate-at-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","LU0175139822.USD","LU0320765489.SGD","LU1035773651.USD","LU1267930573.SGD","BK4539","LU0128525929.USD","LU1280957306.USD","IE00B19Z3B42.SGD","LU0256863811.USD","LU0868494708.USD","LU2461242641.AUD","LU2361045086.USD","BK4588","LU0742534661.SGD","LU0477156953.USD","LU1668664300.SGD","BK4137","LU0128526141.USD","IYF","LU0029864427.USD","IE00B19Z3581.USD","FTXO","LU0128525689.USD","LU0310799852.SGD","LU0052756011.USD","IE00B7SZLL34.SGD","LU0640476718.USD","LU0942090050.USD","LU0648001328.SGD","XBI","LU0162691827.USD","TFNS","PGF","LU2361044949.HKD","XLV","LENZ","IE0002270589.USD","LU0072461881.USD","KBWB","LU0149725797.USD","LU1267930490.SGD","LU0211327993.USD","BK4139","LU0314106906.USD","LU1894683264.USD","LABU","LU0154236417.USD","HCSG","LU1069347547.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855376","title":"SEC, FDA Sign Agreement to Boost Information Sharing, Market Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855376","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855376?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261309,"startTime":"0","endTime":"0","summary":"The Securities and Exchange Commission said Monday that it has entered into a three-year memorandum of understanding with the Food and Drug Administration to strengthen cooperation on regulatory and enforcement matters, including information sharing relevant to both agencies.The agreement is intended to improve market oversight and compliance while supporting the FDA's public health mission, the agency said.\"FDA-related disclosures by public companies have a significant impact on our markets,\" SEC Chairman Paul Atkins said, adding that the MOU will strengthen efforts to \"enforce applicable disclosure requirements under the federal securities laws.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122293255","title":"Xianju Pharmaceutical Receives US FDA Filing Acceptance for Progesterone Vaginal Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1122293255","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122293255?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:04","pubTimestamp":1788260669,"startTime":"0","endTime":"0","summary":"Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ) has announced that its Abbreviated New Drug Application (ANDA) for progesterone vaginal tablets has been formally accepted for review by the U.S....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK0028","SG9999014674.SGD","BK4588","BK4585","BK0239","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985588","title":"RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985588","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985588?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"Together with the previously announced Talicia strategic divestiture, the acquisition from Ferring of commercialization rights to two larger, proprietary, established gastrointestinal (GI) FDA-approve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353970/0/en/redhill-announces-transformational-acquisition-of-commercialization-rights-to-ferring-s-rebyota-and-clenpiq.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664868855","title":"Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664868855","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664868855?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with ser","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353946/0/en/parabilis-medicines-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","COAL","XBI","BK4006","BK4137","BK4585","LU0029874061.USD","PBLS","HCSG","LU0128526141.USD","BK4581","XLV","BK4588","ACP","HCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855897","title":"Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855897","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855897?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"– Following productive FDA discussions, Upstream Bio will study 400 mg of verekitug administered every 12 weeks, versus placebo, in severe asthma and CRSwNP with one pivotal Phase 3 trial in each indi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353967/0/en/upstream-bio-announces-pivotal-phase-3-development-plans-for-verekitug-in-both-severe-asthma-and-crswnp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLQ","TESL","TSLY","TSLR","TEST","09766","BBC","TSLO","LABU","TSLW","TSLT","TSL","TSLZ","07366","ELOL","07766","09366","TSLS","TSLP","CRSH","TLA","TSDD","TSII","TSLI","PSIL","TSLG","TSLL","TSYY","TESC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853162","title":"Press Release: RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota(R) and Clenpiq(R)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853162","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853162?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"Together with the previously announced Talicia strategic divestiture, the acquisition from Ferring of commercialization rights to two larger, proprietary, established gastrointestinal (GI) FDA-approve","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4022","R","RDHL","BK4588","BK4007","BK4232","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485589","title":"Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485589","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485589?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CHAPEL HILL, N.C., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) announced today that Chris Giordano, President & Chief","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353934/12401/en/tenax-therapeutics-to-participate-in-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LU0128526141.USD","BK4585","BK4007","XBI","XLV","BK4539","BK4139","BK4581","HCSG","BK4137","LU0029874061.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664685804","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664685804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664685804?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258644,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-procept-biorobotics-prct-invivyd-ivvd-and-alpha-tau-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-procept-biorobotics-prct-invivyd-ivvd-and-alpha-tau-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRTS","BK4585","LU0128526141.USD","LU2324357040.USD","XBI","LU0029874061.USD","BK4539","PRCT","BK4139","IVVD","HCSG","XLV","BK4137","BK4082","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830282","title":"Alliance Healthcare Wins ALPS Tender for Mobile Inpatient Home Care Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830282?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:48","pubTimestamp":1788256126,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Alliance Healthcare Group Ltd. ( ($SG:MIJ) ). Alliance Healthcare Group has secured a three-year tender from AL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-wins-alps-tender-for-mobile-inpatient-home-care-services?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-wins-alps-tender-for-mobile-inpatient-home-care-services?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","SG","BK4585","XBI","HBCP","BK4195","XLV","BK4581","HCSG","BK4137","BK4209","LU0029874061.USD","BK4588","LABU","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":16,"totalSize":410,"code":"91000000","status":"200"}]}}